DrugId:  1
1. Name:  Tapinarof
2. Groups:  Investigational
3. Description:  Tapinarof is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease.
4. Indication:  Investigated for use/treatment in psoriasis and psoriatic disorders.
DrugId:  2
1. Name:  Doxycycline
2. Groups:  Approved, Investigational, Vet approved
3. Description:  A synthetic tetracycline derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (malaria, falciparum).
4. Indication:  Doxycycline is indicated for use in respiratory tract infections caused by Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Legionella spp., or Klebsiella spp. It is also used for prophylaxis of malaria. Doxycycline is indicated for a variety of bacterial infections, from Mycobacterium fortuitum and M. marinum, to susceptible E. coli and Brucella spp. It can be used as an alternative to treating plague, tetanus, Campylobacter fetus 
DrugId:  3
1. Name:  Streptomycin
2. Groups:  Approved, Vet approved
3. Description:  Streptomycin is an aminoglycoside antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by binding to the 30S ribosomal subunit of susceptible organisms and disrupting the initiation and elongation steps in protein synthesis. It is bactericidal due to effects that are not fully understood.
4. Indication:  For the treatment of tuberculosis. May also be used in combination with other drugs to treat tularemia (Francisella tularensis), plague (Yersia pestis), severe M. avium complex, brucellosis, and enterococcal endocarditis (e.g. E. faecalis, E. faecium).
